Ingredion's Recipe for Resilience: Argo Recovery and a 7% T&HS Quarter

In the shadow of a transformational Tate & Lyle deal, Ingredion's Texture & Healthful engine keeps compounding.

INGR · Earnings Call · 2026-08-04

Q2: A Tale of Two Ingredions

Ingredion's second quarter was a study in contrasts. On one hand, the Food & Industrial Ingredients U.S./Canada segment continued to limp, still healing from the Argo reliability saga that has dogged the company for over a year. On the other, the Texture & Healthful Solutions (T&HS) segment delivered its second-highest quarterly operating income ever, with net sales volumes up 7% year-over-year — the ninth consecutive quarter of volume growth. “We are pleased to say that Argo reliability and production sequentially improved during the quarter, and at the end of June, the plant was operating at normal production rates across all major operating units.” — James Zallie, Chairman, President and CEO · 2026-08-04 That optimism was tempered by a 5% decline in adjusted operating income, dragged by Argo-related costs, inflationary tapioca pressures, and a softer Mexican economy. The Argo story has been a recurring theme since early 2025. On the prior quarter's call, Jim Gray quantified the damage: “In Q4, the primary issue was the operational challenges there. ... That was the impact to the U.S./CAN F&I segment in Q4.” — Jim Gray, Executive Vice President and CFO · 2026-02-03 Now, management says the grind, refinery, and even the thermal-event-damaged germ unit are all running at normalized rates. The company has taken targeted actions — from root-cause analysis to added saccharification-tank redundancy — and expects the facility to regain historical margins by year-end.

Texture & Healthful: The Engine That Won't Sputter

The real highlight is T&HS. Despite tapioca price increases of over 40% year-to-date, the segment grew volumes 7%, with broad-based strength across solutions and clean label ingredients. Management stresses that these gains are structural, not pulled forward.

We don't think there's any pull forward in the Q2 numbers. We're pleased with the 7% net sales volume growth, and we're pleased that it was our ninth consecutive quarter of sales volume growth.
James Zallie, Chairman, President and CEO · 2026-08-04

The pricing lag — roughly 1 to 1.5 quarters — will compress near-term margins, but the company has historically benefited when tapioca prices eventually deflate. What's driving this momentum? Insurgent brands and private-label innovations are picking up speed, and in the current call, Jim Zallie highlighted a reoriented go-to-market model: “We also are very focused on the growth of insurgent brands. And these kind of start-up companies really – if you are formulated into their winning products, they are driving the majority of the organic volume growth in the food industry.” — James Zallie, Chairman, President and CEO · 2026-08-04 The launch of Ask Ingredion — an AI-powered formulation platform — and the acquisition of Benicaros (an immune-health prebiotic) underscore the company's push into higher-value, science-backed solutions.

The Tate & Lyle Catalysts and Portfolio Reshaping

Beyond the quarter's operational details, the pending acquisition of Tate & Lyle remains the strategic centerpiece. Shareholder approval was secured last week, and regulatory reviews are underway. Management reiterated $2.7 billion of complementary revenue, $130 million of run-rate synergies by 2030, and greater than 15% adjusted EPS accretion in the first full year. The deal would push more than half of Ingredion's revenue into the fastest-growing T&HS segment.Net debt stood at $905 million, giving the company ample headroom to fund synergies and integration. Simultaneously, Ingredion is pruning its low-margin businesses — selling its majority stake in the Pakistan business and closing a plant in Brazil. These moves align with the enterprise productivity pillar and the pivot to organic volume growth in specialty applications. Management also flagged the Middle East response team, a dedicated task force managing energy-driven cost inflation, which they estimate will have a manageable few-million-dollar net impact.

Outlook and Risks

For 2026, the company reaffirmed adjusted EPS of $10.30–$10.90, but now expects adjusted operating income to be down mid-single digits — due to the Pakistan divestiture — and Argo's recovery is built into the second half. Q3 will see sequentially higher corporate costs and an unwind of the $2 million Sanstar mark-to-market gain. The Mexican peso's recent strength adds transactional headwinds, though management remains confident in the region's long-term fundamentals. On the cost side, corn prices are expected to be elevated, but the company's hedging program and pass-through mechanisms have historically preserved earnings stability. As Jim Zallie noted, "We would not expect changes in corn prices alone to really impact margins or alter our long-term outlook."“We've successfully managed through multiple corn cycles using a combination of disciplined hedging and pass-through pricing.” — James Zallie, Chairman, President and CEO · 2026-08-04 The stock is down about 31% from its late-2024 peak, and the recent 90-day return is -6.8%. Yet the fundamental story is improving: Argo's reliability, T&HS's sustained volume growth, and a clear strategic roadmap with Tate & Lyle could make this a compelling inflection point for investors willing to look past the near-term cost headwinds.